Farther Finance Advisors’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
Farther Finance Advisors's CGEM Position: Q3 2026 in Review
Farther Finance Advisors increased its Cullinan Oncology (CGEM) stake by 11% in Q3 2026, buying an estimated $1.78K and bringing the position to 942 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4396.
Farther Finance Advisors first reported a position in CGEM in Q1 2025 and has held it in 7 quarters since. The position peaked at $15.5K in Q2 2026. 4 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Farther Finance Advisors held 942 shares of Cullinan Oncology worth $14.5K as of Q3 2026.
- Farther Finance Advisors bought 93 Cullinan Oncology shares in Q3 2026, an estimated $1.78K.
- Cullinan Oncology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4396 holding.
- Farther Finance Advisors first reported a position in Cullinan Oncology in Q1 2025 and has held it in 7 quarters since.
- Farther Finance Advisors's Cullinan Oncology position peaked at $15.5K in Q2 2026.
- 4 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.